Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06373861 · ClinicalTrials.gov registry record
Generating Advancements Through Longitudinal Analysis in X and Y Variations (GALAXY)
A clinical trial of Sex Chromosome Aneuploidy, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT06373861: Recruiting study of Sex Chromosome Aneuploidy, sponsored by University of Colorado, Denver.
NCT06373861 is a study of Sex Chromosome Aneuploidy that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 5,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06373861, a study of Sex Chromosome Aneuploidy, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
GALAXY is a registry research study that plans to learn more about individuals with X\&Y variations (also called sex chromosome aneuploidies) through collecting information from medical records.This includes genetic tests, imaging, medications, and more for hundreds of patients seen at a number of clinics across the US. The purpose of the GALAXY Registry is to collect and store this information with the overall goal to improve health outcomes in individuals with X\&Y variations and the care they receive.
Primary Outcome
Average number of chronic diagnoses per person
Conditions Studied
Interventions
- OTHER no intervention
Study Locations (1)
Colorado
- Children's Hospital Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2022-04-28 |
| Est. Completion | 2037-04 |
What NCT06373861 shows while recruiting
NCT06373861 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Sex Chromosome Aneuploidy appearing as the primary indexed condition, and to 1 intervention - of which no intervention is the first listed.
NCT06373861 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT06373861 about?
NCT06373861 is a clinical study titled "Generating Advancements Through Longitudinal Analysis in X and Y Variations (GALAXY)". GALAXY is a registry research study that plans to learn more about individuals with X\&Y variations (also called sex chromosome aneuploidies) through collecting information from medical records.This includes genetic tests, imaging, medications, and more for hundreds of patients seen at a number of c...
What is the current status of trial NCT06373861?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2022-04-28. Estimated completion is 2037-04.
What conditions does trial NCT06373861 study?
This clinical trial studies the following conditions: Sex Chromosome Aneuploidy.
What interventions are being tested in trial NCT06373861?
The interventions under investigation include: no intervention (OTHER).
Who is sponsoring clinical trial NCT06373861?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06373861 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sex Chromosome Aneuploidy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI